SKIP4 Antibody

Analysis of "SKIP" in Antibody Context

Search Result describes an antibody targeting Skp1 (S-phase kinase-associated protein 1), a component of the SCF ubiquitin ligase complex. While Skp1 is involved in cell cycle regulation and protein degradation, there is no established link to a "SKIP4" variant.

IgG4 Antibodies: A Potential Misinterpretation

The term "SKIP4" might inadvertently reference IgG4 antibodies, a subclass of immunoglobulins with unique properties:

Antibody Nomenclature and Databases

Search Result lists over 100 approved antibody therapeutics, but none align with "SKIP4." Similarly, Search Result on bispecific antibodies (BsAbs) and Search Result on antibody sequence datasets do not mention this term.

Potential Research Gaps

• Technical Limitations: Detection methods (e.g., ELISA, immunocytochemistry) may fail to identify low-abundance or conformation-specific antibodies, as seen in studies targeting KIR4.1 in multiple sclerosis .

• Naming Conventions: "SKIP4" could represent an internal or obsolete designation not yet cataloged in public databases like the IEDB or the Antibody Society’s therapeutic listings .

Recommendations for Further Investigation

1. Verify Terminology: Confirm whether "SKIP4" refers to a specific antigen (e.g., SKI-interacting protein 4) or a proprietary antibody clone.

2. Explore Homologous Targets: Investigate antibodies targeting related proteins (e.g., SKIP, Skp1, or IgG4 subclass antibodies).

3. Consult Specialized Databases:

   • IEDB (Immune Epitope Database) for sequence data .

   • ClinicalTrials.gov for ongoing studies involving novel antibodies.